![Beta-blocker/ACE inhibitor therapy differentially impacts the steady state signaling landscape of failing and non-failing hearts | Scientific Reports Beta-blocker/ACE inhibitor therapy differentially impacts the steady state signaling landscape of failing and non-failing hearts | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-022-08534-0/MediaObjects/41598_2022_8534_Fig1_HTML.png)
Beta-blocker/ACE inhibitor therapy differentially impacts the steady state signaling landscape of failing and non-failing hearts | Scientific Reports
![Table 1 from Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction: Results From the HF-ACTION Trial. | Semantic Scholar Table 1 from Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction: Results From the HF-ACTION Trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d74cb01d7491e0648e608b1b314629930ea1a050/3-Table1-1.png)
Table 1 from Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction: Results From the HF-ACTION Trial. | Semantic Scholar
25 Supplementary tables Supplementary table 1: Conversion table RAS- and beta-blocker Adapted from Schmidt et al. 16
![Comparación del cumplimiento de las guías para fallo cardíaco crónico sistólico en dos clínicas ambulatorias Comparación del cumplimiento de las guías para fallo cardíaco crónico sistólico en dos clínicas ambulatorias](https://scielo.isciii.es/img/revistas/pharmacy/v8n1/original6_t2.gif)
Comparación del cumplimiento de las guías para fallo cardíaco crónico sistólico en dos clínicas ambulatorias
![CARDENE(R) I.V. (NICARDIPINE HYDROCHLORIDE) PREMIXED INJECTION IN 4.8% DEXTROSE 20mg IN 200mL (0.1mg/mL) 200mL BAG CARDENE(R) I.V. (NICARDIPINE HYDROCHLORIDE) PREMIXED INJECTION IN 4.8% DEXTROSE 20mg IN 200mL (0.1mg/mL) 200mL BAG](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=Highlights+2.jpg&id=461352)
CARDENE(R) I.V. (NICARDIPINE HYDROCHLORIDE) PREMIXED INJECTION IN 4.8% DEXTROSE 20mg IN 200mL (0.1mg/mL) 200mL BAG
![Table 5 from Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy). | Semantic Scholar Table 5 from Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy). | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/756f1a156300486fff78e90803b94ee14c5b9b76/7-Table5-1.png)